Ero sivun ”Kalanmaksaöljy” versioiden välillä

| volume = 295 | issue = 4 | pages = 403–415 | pmid = 16434631 | url =http://jama.ama-assn.org/cgi/content/short/295/4/403| accessdate = 2006-07-07 | doi = 10.1001/jama.295.4.403|author-separator = ,| author2 = Catherine H.| display-authors = 2| last3 = Mojica| first3 = WA| last4 = Khanna| first4 = P|last5 = Issa| first5 = AM| last6 = Suttorp| first6 = MJ| last7 = Lim| first7 = YW| last8 = Traina| first8 = SB| last9 = Hilton| first9 = L }}</ref>), ja yhdysvaltain terveysviranomaiset ovat myös varoittaneet turhien omega-3 lisäkkeiden syömisen vaaroista <ref name=Lewis>{{cite web|last=Lewis |first=Christine J.|url=http://www.fda.gov/ohrms/dockets/dockets/95s0316/95s-0316-Rpt0272-38-Appendix-D-Reference-F-FDA-vol205.pdf|title=Letter Regarding Dietary Supplement Health Claim for Omega-3 Fatty Acids and Coronary Heart Disease}} and {{cite web|title=Letter Regarding Dietary Supplement Health Claim for Omega-3 Fatty Acids and Coronary Heart Disease|url=http://vm.cfsan.fda.gov/~dms/ds-ltr11.html |date=October 31, 2000|publisher=U.S. Food and Drug Administration via Internet Archive|accessdate=2009-10-30 |archiveurl =http://web.archive.org/web/20061217002249/http://vm.cfsan.fda.gov/~dms/ds-ltr11.html |archivedate = 2006-12-17}}</ref>.

 

 

== Lähteet ==